The Company was incorporated on 16th April, 1990 under the Act as a
Private Limited Company under the name of CAPLIN POINT LABORATORIES
PRIVATE LIMITED. The name of the Company was changed to CAPLIN
POINT LABORATORIES LIMITED effective 23rd April 1993. The Company
has adopted a new set of Articles on 12th March, 1993 as applicable
to public limited companies.
The Company was incorporated as an extension of a pharmaceutical
manufacturing unit started by M/s Triwin Pharmaceuticals, the first
pharmaceutical venture started by Mr. P C Partheeban (presently the
Managing Director), Mr. T Palanisamy and Mr. S Karunakaran in the
year 1987 as a partnership firm. In the year 1990, the Company was
incorporated by the partners of the aforesaid firm alongwith Mr. B A
Ahmed. Soon thereafter, Mr. S Jayaraman joined the Board to take
charge of production.
Recently, the Board has been recast with all Directors except
Mr.P.C.Partheeban making room for broadbasing the Board. The
resigning Directors have taken positions as Senior level Managers in
M/s Triwin Pharmaceuticals was engaged in the business of manufacture
of Tablets, Liquid orals and Capsules (Non-Antibiotic) and Import
Sales of family planning and certain life saving drugs. The said
firm also started the Export of manufactured formulations in the year
Even after the incorporation of the Company, the firm continued its
manufacturing, sales and export of Tablets, Liquid orals and Capsules
(Non-Antibiotic) and business of import sales while the Company
started the manufacture of Ointments, Oral Powders and Capsules
The said firm has since been taken over by the Company with effect
from 1st September, 1993 with the objective of consolidation of the
business of the Company into a single larger entity for setting up
the Project envisaged. All the assets and liabilities of the firm
were taken over at book values as at 31st August 1993. The Company's
future shall comprise of the sales generated from the manufacturing
faculties of the erstwhile firm also. Salient terms of the takeover
Agreement executed by the Company with M/s. Triwin Pharmacuticals
('Triwin') are as follows.
a. Transfer and vesting of assets and liabilities of Triwin in the
All the assets and liabilities of Triwin including its factory
located at No. 44, Kamakoti Nagar Annexe,Valasaravakkam, Madras 600
087, on going business basis are transferred at book values as on
31st August 1993.
b. Net consideration for the transfer of assets and liabilities
Consideration payable by the Company shall be the net worth of Triwin
(excluding good will) estimated at Rs.31,62,000 on the basis of its
audited accounts as at 31st August 1993.
c. Continuance of Business
In the post-transfer stage, the Company to continue to do the
business then carried on by Triwin (including the manufacturing
operation) and Triwin shall suspend all the production/sales
activities hitherto carried on by them.
d. Discharge of Purchase consideration
The Company to issue at par its Shares credited as fully paid-up to
the partners of Triwin for an aggregate nominal value of Rs.
31,62,000 (Rupees Thirty One lacs Sixty Two Thousand only) in the
proportion of amounts lying to the credit of the respective
capital/current accounts as on 31st August 1993.
-Caplin Point Laboratories Ltd has recommended a final dividend of
Re. 1/- per share (10%)
-Caplin Point Laboratories Ltd has Recommended a final Dividend of
Re. 1.50 per share (15%)
-Mr. Vivek Siddharth has been appointed as the Chief Operating
Officer of the Company
-Caplin Point Laboratories Ltd has recommended dividend a final
dividend of Rs. 2/- per share (20%)
-Mr. D. P. Mishra has been appointed as a Whole Time Director of the
-Mr. Mohanraj has been appointed as the Vice President - Finance and
Company Secretary of the company.
-Caplin has commenced its additional line of Production in the area
of Suppositories which is unique in its feature which very few Pharma
-Caplin Point Lab gets listing on Forbes Asia and rsquo;s ‘200
Best Billion and rsquo; 2014.
-Caplin Point Lab - Caplin Point gets EU GMP approval for Sterile
-Caplin Point Lab - Caplin Point gets Brazil's Anvisa approval for
Sterile Injectable Site